Moro M L, Pantosti A, Boccia D
Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanità, Roma.
Ann Ig. 2002 Sep-Oct;14(5):361-71.
This paper presents the results of an Italian multicentric study conducted in the period April 1999-April 2000 in 64 clinical microbiology laboratories, aimed at collecting antimicrobial resistance data using a standard European protocol (EARSS Project, European Antimicrobial Surveillance System). A total of 1701 strains of Staphylococcus aureus were isolated from blood and 367 strains of Streptococcus pneumoniae were isolated from blood (72.7%) or from CSF (27.3%). Methicillin resistance in S. aureus was found to be 42.1%; it was significantly higher in adults (RR = 6.6, CI 95% 2.5-17.0), in hospitals of Centre and North of Italy (respectively RR = 1.45, CI 95% 1.1-2.0; RR = 1.6, CI 95% 1.1-2.2), and in intensive care and surgery units (respectively RR = 1.8, IC 95% 1.6-2.0 and RR = 1.7, CI 95% 1.4-1.9). Penicillin resistance in S. pneumoniae was found to be 12.1%; it was higher in South Italy (RR = 3.5, CI 95% 1.9-6.6, in meningitis compared to sepsis (RR = 2.5, CI 95% 1.4-2.5) and in intensive care units compared to other departments (RR = 2.2, CI 95% 1.0-4.8). The level of erythromycin resistance in S. pneumoniae was of 28.2%, reaching 56.4% in penicillin resistant strains. These results suggest that a continued surveillance and effective control measures are required.
本文介绍了一项意大利多中心研究的结果,该研究于1999年4月至2000年4月期间在64个临床微生物实验室进行,旨在使用标准的欧洲方案(EARSS项目,欧洲抗菌药物监测系统)收集抗菌药物耐药性数据。共从血液中分离出1701株金黄色葡萄球菌,从血液(72.7%)或脑脊液(27.3%)中分离出367株肺炎链球菌。发现金黄色葡萄球菌的耐甲氧西林率为42.1%;在成年人中显著更高(相对风险RR = 6.6,95%置信区间CI为2.5 - 17.0),在意大利中部和北部的医院中(相对风险分别为RR = 1.45,95%置信区间CI为1.1 - 2.0;RR = 1.6,95%置信区间CI为1.1 - 2.2),以及在重症监护和外科病房中(相对风险分别为RR = 1.8,95%置信区间CI为1.6 - 2.0和RR = 1.7,95%置信区间CI为1.4 - 1.9)。发现肺炎链球菌的青霉素耐药率为12.1%;在意大利南部更高(相对风险RR = 3.5,95%置信区间CI为1.9 - 6.6),在脑膜炎患者中与败血症患者相比(相对风险RR = 2.5,95%置信区间CI为1.4 - 2.5),以及在重症监护病房与其他科室相比(相对风险RR = 2.2,95%置信区间CI为1.0 - 4.8)。肺炎链球菌的红霉素耐药水平为28.2%,在青霉素耐药菌株中达到56.4%。这些结果表明需要持续监测和采取有效的控制措施。